ReviewFrontiers in pharmacology2022
Review in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 39 citations in OpenAlex.
- Bioactive Peptides From theFood science & nutrition · 2026Review
- Observational
- Endophytic fungus Muyocopron dipterocarpi isolated from Catharanthus roseus as a novel producer of ajmalicine and other metabolites: insights from HPLC and LC-HRMS analysis.Antonie van Leeuwenhoek · 2026Article
- Review
- Protective Effects ofPharmaceuticals (Basel, Switzerland) · 2026Article
- Bioactive Compounds ofInternational journal of molecular sciences · 2026Article
- A traditional herbal remedy in liver diseases:Hepatology forum · 2026Review
- Review
- Echinocystic acid inFrontiers in medicine · 2025Article
- Multidimensional Uses of Bitter Melon (Current organic synthesis · 2025Review
- Therapeutic Potential of Momordicine I fromInternational journal of molecular sciences · 2024Review
- The Role of Fenugreek in the Management of Type 2 Diabetes.International journal of molecular sciences · 2024Review
- Quorum quenching mediated biofilm impediment inHeliyon · 2024Article
- Management of diabetes mellitus using medicinal plants: A review.Bioinformation · 2024Review
- Optimization of Magnetic and Paper-Based Molecularly Imprinted Polymers for Selective Extraction of Charantin inInternational journal of molecular sciences · 2023Article
- Anti-Glucotoxicity Effect of PhytoconstituentsInternational journal of molecular sciences · 2023Review
- Ethnopharmacological Value and Biological Activities via Antioxidant and Anti-Protein Denaturation Activity ofPlants (Basel, Switzerland) · 2023Article
- Natural products for the treatment and management of diabetes mellitus in Zimbabwe-a review.Frontiers in pharmacology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.